FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes
Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.
Digitalization | 22/01/2026 | By News Bureau | 113
HistoIndex, Houston Research Institute Collaborate to Enhance MASH Diagnosis Using AI
HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has entered into a strategic partnership with Houston Research Institute (HRI), a leading clinical research organization specialising in hepatology and gastroenterology, with a strong focus on metabolic liver disease.
Digitalization | 22/01/2026 | By Darshana
Graph Therapeutics Taps Parse GigaLab to Accelerate AI-First Immunology Drug Discovery
Parse Biosciences and Graph Therapeutics have entered into a strategic partnership to build one of the largest and most comprehensive immune cell perturbation atlases to date.
Digitalization | 22/01/2026 | By Darshana | 117
HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care
HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.
Digitalization | 21/01/2026 | By News Bureau | 100
PharmaCloud Bridges Innovation and Compliance in Pharma Manufacturing Operations
Pharma manufacturing continues to grapple with a long-standing challenge: balancing innovation with strict regulatory compliance. While AI-driven technologies have the potential to significantly enhance operator capability and execution consistency, their adoption on the shop floor is often constrained by regulatory and validation requirements.
Digitalization | 20/01/2026 | By Darshana | 101
Viz.ai Launches Real-Time Clinical Intelligence Service for Salesforce Agentforce Life Sciences
The new service integrates Viz.ai’s real-time clinical data from nearly 2,000 hospitals to power intelligent, closed-loop agentic workflows for life sciences organisations.
Digitalization | 16/01/2026 | By News Bureau | 242
Illumina Launches Billion Cell Atlas to Power AI-Driven Drug Discovery
Illumina, Inc. has launched the Illumina Billion Cell Atlas, the world’s largest genome-wide genetic perturbation dataset, designed to accelerate AI-enabled drug discovery across the pharmaceutical industry.
Digitalization | 15/01/2026 | By Darshana | 186
US and European Regulators Set Principles for Responsible AI Use in Drug Development
US and European medicines regulators have jointly issued a set of guiding principles to support the safe, effective and responsible use of artificial intelligence (AI) in drug development, marking a significant step toward regulatory alignment on emerging technologies.
Digitalization | 15/01/2026 | By Darshana | 175
TetraScience, Thermo Fisher Collaborate to Accelerate AI in Biopharma R&D and Manufacturing
The partnership between TetraScience and Thermo Fisher aims to transform fragmented scientific data into AI-native workflows, enabling faster, scalable and more efficient drug development and manufacturing.
Digitalization | 13/01/2026 | By News Bureau | 147
Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants
Experts at a national seminar hosted by IIT Delhi emphasised the need for AI-enabled farm-gate quality assessment and traceability to strengthen India’s medicinal plant supply chain, outlining a digital roadmap to enhance the global competitiveness of AYUSH raw materials.
Digitalization | 13/01/2026 | By News Bureau | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy